More Adherium Ltd. news Adherium Ltd.ASX: ADR Adherium Smartinhaler used in Global Mild-Asthma Studies May 21, 2018 at 12:18 AM EDT · Issued by Adherium Ltd. Filed with ASX · May 21, 2018 at 12:18 AM EDTOn 6ix: 6ix.com/news/adherium-smartinhaler-used-in-global-mild-asthma-studiesAdherium Ltd has released a press release. View Attachment6ix hasn’t read this filing yet. Read this filing Adherium Ltd. on 6ix Story so farNICE reports on Adherium Smartinhaler for asthma managementJan 12, 2017Adherium Smartinhaler dramatically improves outcomesNov 17, 2016Adherium Smartinhaler in AstraZeneca COPD StudyJun 14, 2016 Earlier from AdheriumAdherium launches new global brand HailieMay 16, 2018Adherium Announces Program with Vitalus HealthMay 1, 2018Adherium receives US FDA 510k OTC clearanceMar 27, 2018Asthma Adherence Management FindingsMar 7, 2018Adherium Investor Conference CallFeb 6, 2018Later from AdheriumAdherium Program with Connecticut Childrens Medical CenterJul 10, 2018Adherium Receives Additional US FDA 510(k) ClearanceJul 26, 2018Adherium Launches Hailie™ Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD ManagementAug 13, 2018Adherium and Vitalus Health Launch Commercial ProgramAug 23, 2018Adherium Announces Q1 Fiscal Year 2019 Investor Conference CallOct 25, 2018All Adherium news releases↗Follow Adherium into a list and get an email when it puts out news.Follow Adherium